CYTK insider trading
HealthcareCYTOKINETICS INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About CYTOKINETICS INC
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure. It also develops CK- 089, a fast skeletal muscle troponin activator that is in Phase I clinical trial; CK-586, a small molecule cardiac myosin inhibitor, that is in Phase II clinical trial; and aficamten, a novel, oral, small molecule cardiac myosin inhibitor which is in Phase III clinical trial discovered for the treatment of hypertrophic cardiomyopathy. It has a strategic alliance with Ji Xing Pharmaceuticals Limited; and a collaboration and license agreement for the development and commercialization of aficamten in Japan for the treatment of patients with obstructive and non-obstructive hypertrophic cardiomyopathy. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
Company website: www.cytokinetics.com
CYTK insider activity at a glance
FilingIQ has scored 1,483 insider transactions for CYTK since Mar 15, 2006. The most recent filing in our index is dated May 14, 2026.
Across the full history, 17 open-market purchases
and 607 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on CYTK insider trades is 62.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest CYTK Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading CYTK
13F funds holding CYTK
Frequently asked
- How many insider trades does FilingIQ track for CYTK?
- FilingIQ tracks 1,483 Form 4 insider transactions for CYTK (CYTOKINETICS INC), covering filings from Mar 15, 2006 onwards. 78 of those were filed in the last 90 days.
- Are CYTK insiders net buyers or net sellers?
- Across the full Form 4 history for CYTK, 17 transactions (1%) were open-market purchases and 607 (41%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CYTK insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is CYTK in?
- CYTOKINETICS INC (CYTK) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $8.10B.
Methodology & sources
Every CYTK insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.